ArticleCancer immunology, immunotherapy : CII2025
Exploration of the benefits and resistance mechanisms of immunotherapy based on PD-L1 expression, circulating tumor DNA and T-cell receptor profiles in advanced gastric cancer.
Miaomiao Gou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.